In March this year it was announced that the combination of bevacizumab (Avastin) with docetaxel and prednisone had no benficial impact (in a large Phase III trial) on the overall survival of men with… more →
THE "NEW" PROSTATE CANCER INFOLINKwrote 3 years ago: In March this year it was announced that the combination of bevacizumab (Avastin) with docetaxel and … more →